Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

Comparison of a 2D digital mammogram and breast tomosynthesis 3D mammography from UCSF.

ACR & SBI: Mammo not dangerous to thyroid

In response to an erroneous media report, the American College of Radiology (ACR) and the Society of Breast Imaging (SBI) released a joint statement urging patients to disregard trumped up risks of thyroid cancer due to mammography-induced radiation.

New ASE guidelines offer clarity for right ventricular assessment

The American Society of Echocardiography (ASE) has published new guidelines to improve the existing norms of the right heart in the July issue of the Journal of the American Society of Echocardiography. The recommended procedures will establish a more uniform method of evaluating the size and function of the right ventricle, said the society.

ASE: Biomarkers may predict chemo-related cardiotoxicity

According to research presented during the 21st annual scientific sessions of the American Society of Echocardiography (ASE) in San Diego this week, cardiac troponin plasma concentrations and longitudinal strain can predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab chemotherapies.

LightLab Imaging debuts new OCT system at EuroPCR

Optical coherence tomography (OCT) developer LightLab Imaging has launched its C7XR FD-OCT imaging system with the C7 Dragonfly Imaging Catheter at EuroPCR 2009 in Barcelona, Spain.

ASE recommends contrast agent usage in echoes

The American Society of Echocardiography (ASE) has issued a consensus statement, supporting the use of contrast agents used to enhance echocardiogram images, and providing a guide for physicians who may be hesitant to use the contrast agents following a 2007 FDA black-box warning. The statement was published in the November issue of Journal of the American Society of Echocardiography.

EuroPCR: Xience continues to perform better than Taxus at two years

Two-year data from the SPIRIT III trial, Abbott’s U.S. pivotal trial,demonstrated that its Xience V everolimus-eluting coronary stent systemcontinues to deliver clinically superior benefits compared to BostonScientific’s Taxus paclitaxel-eluting coronary stent system, accordingto a presentation at a late-breaking clinical trials session at EuroPCR2008 in Barcelona, Spain.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

These risks appear to be present regardless of a person's age or health at the time of infection.

Agfa and Sectra both performed well with end-user satisfaction scores in the 2025 Best in KLAS list of radiology IT systems.